Loading...
Loading...
Browse all stories on DeepNewz
VisitBrookfield Abandons Grifols Acquisition, Stock Plummets
Nov 27, 2024, 09:01 AM
Brookfield Asset Management is reportedly preparing to abandon its plans to acquire Spanish drug-maker Grifols SA due to disagreements over valuation. Grifols' board recently rejected Brookfield's indicative offer, leading to a significant drop in Grifols' stock price. The shares fell as much as 17% after the news broke, with the company's stock plummeting by 12% on the day. The potential withdrawal of the offer has also impacted the broader market, with the IBEX 35 index losing 11,600 points. The Grifols family has indicated they won't support a new bid by a third-party to take the company private.
View original story
Markets
Yes • 50%
No • 50%
Official announcements from Brookfield Asset Management or Grifols SA
No • 50%
Yes • 50%
Stock price data from financial platforms like Bloomberg or Yahoo Finance
No • 50%
Yes • 50%
IBEX 35 index data from financial platforms like Bloomberg or Yahoo Finance
Underperform IBEX 35 • 25%
Significant Underperformance • 25%
Outperform IBEX 35 • 25%
Match IBEX 35 • 25%
Stock performance data from financial platforms like Bloomberg or Yahoo Finance
Partnership with Another Company • 25%
New Acquisition Target • 25%
No Major Change • 25%
Restructuring Plan • 25%
Official announcements from Grifols SA
No Acquisition • 25%
Brookfield Asset Management • 25%
Private Equity Firm • 25%
Pharmaceutical Company • 25%
Official announcements from Grifols SA or potential acquiring companies